State Senate Passes Insulin Reform

After more than 12 months of discussion, analysis, and debate, the Senate unanimously passed a strong insulin safety net bill on Thursday. House File 3100 prioritizes renewability, portability, and prompt implementation.

This program is designed to be available for all who need it and includes fulfillment of both urgent and ongoing needs for patients. Most importantly, this bill provides 30 days of emergency insulin to anyone regardless of income as long as they are Minnesota residents and in need of the medicine. All insulin in the Senate plan is provided by the insulin companies with affordable co-pays. A long-term component to the program helps patients with qualifying incomes afford their insulin with a 90-day supply for no more than a $25 co-pay.

House File 3100 also includes a program review by the legislative auditor to determine if the manufacturers are meeting their responsibilities. Additionally, the Minnesota Department of Health (MDH) in consultation with the Board of Pharmacy will develop and conduct a survey for individuals participating in the insulin programs and report to the legislature.

Finally, this legislation requires health plans to provide written notice to enrollees with dependent child coverage that the dependent child’s coverage ends when the child reaches the age of 26.This bill will sunset December 31, 2023. A conference committee with House members is expected to begin meeting in the next few days.